These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11903511)

  • 1. 5-fluorocytosine-related bone-marrow depression and conversion to fluorouracil: a pilot study.
    Vermes A; Guchelaar HJ; van Kuilenburg AB; Dankert J
    Fundam Clin Pharmacol; 2002 Feb; 16(1):39-47. PubMed ID: 11903511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity.
    Diasio RB; Lakings DE; Bennett JE
    Antimicrob Agents Chemother; 1978 Dec; 14(6):903-8. PubMed ID: 742878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic studies with 5-fluorocytosine-6-14C in mouse, rat, rabbit, dog and man.
    Polak A; Eschenhof E; Fernex M; Scholer HJ
    Chemotherapy; 1976; 22(3-4):137-53. PubMed ID: 773604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive 19F MR spectroscopy of 5-fluorocytosine to 5-fluorouracil conversion by recombinant Salmonella in tumours.
    Dresselaers T; Theys J; Nuyts S; Wouters B; de Bruijn E; Anné J; Lambin P; Van Hecke P; Landuyt W
    Br J Cancer; 2003 Nov; 89(9):1796-801. PubMed ID: 14583786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flucytosine: correlation between toxicity and pharmacokinetic parameters.
    Vermes A; van Der Sijs H; Guchelaar HJ
    Chemotherapy; 2000; 46(2):86-94. PubMed ID: 10671757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous detection of 5-fluorocytosine and 5-fluorouracil in human cells carrying CD/5-FC suicide gene system by using capillary zone electrophoresis.
    Liu Y; Zhu P; Huang Z; Zhou L; Shi P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1076():1-7. PubMed ID: 29353670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
    Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
    Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine.
    Wallace PM; MacMaster JF; Smith VF; Kerr DE; Senter PD; Cosand WL
    Cancer Res; 1994 May; 54(10):2719-23. PubMed ID: 8168103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microflora.
    Harris BE; Manning BW; Federle TW; Diasio RB
    Antimicrob Agents Chemother; 1986 Jan; 29(1):44-8. PubMed ID: 3729334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.
    Haberkorn U; Oberdorfer F; Gebert J; Morr I; Haack K; Weber K; Lindauer M; van Kaick G; Schackert HK
    J Nucl Med; 1996 Jan; 37(1):87-94. PubMed ID: 8544010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients.
    Nemunaitis J; Cunningham C; Senzer N; Kuhn J; Cramm J; Litz C; Cavagnolo R; Cahill A; Clairmont C; Sznol M
    Cancer Gene Ther; 2003 Oct; 10(10):737-44. PubMed ID: 14502226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
    You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.
    Hull WE; Port RE; Herrmann R; Britsch B; Kunz W
    Cancer Res; 1988 Mar; 48(6):1680-8. PubMed ID: 3125967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor efficiency of the cytosine deaminase/5-fluorocytosine suicide gene therapy system on malignant gliomas: an in vivo study.
    Lv SQ; Zhang KB; Zhang EE; Gao FY; Yin CL; Huang CJ; He JQ; Yang H
    Med Sci Monit; 2009 Jan; 15(1):BR13-20. PubMed ID: 19114960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting toxicity during 5-fluorocytosine (5-FC) therapy by plasma level monitoring: a lesson to learn from cytostatic 5-fluorouracil (5 FU) pro-drugs.
    Guentert TW
    J Chemother; 1989 Jul; 1(4 Suppl):1287-9. PubMed ID: 16312868
    [No Abstract]   [Full Text] [Related]  

  • 16. An accelerated stability study of 5-flucytosine in intravenous solution.
    Vermes A; van der Sijs H; Guchelaar HJ
    Pharm World Sci; 1999 Feb; 21(1):35-9. PubMed ID: 10214667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of flucytosine and fluorouracil in human plasma by high-performance liquid chromatography.
    Toraño JS; Vermes A; Guchelaar HJ
    Biomed Chromatogr; 2001 Apr; 15(2):89-94. PubMed ID: 11268048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of pharmacokinetics of 5-FU and alpha-fluoro-beta-alanine, a metabolite of 5-FU, in plasma after administration of UFT, tegafur, 5-FU or doxifluridine to rats].
    Kuwata K; Nagayama S; Hirakawa Y; Matsushima E; Kawaguchi Y
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):885-90. PubMed ID: 10897216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia.
    Nishikawa Y; Funakoshi T; Horimatsu T; Miyamoto S; Matsubara T; Yanagita M; Nakagawa S; Yonezawa A; Matsubara K; Muto M
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):629-633. PubMed ID: 28204913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro study on the active conversion of flucytosine to fluorouracil by microorganisms in the human intestinal microflora.
    Vermes A; Kuijper EJ; Guchelaar HJ; Dankert J
    Chemotherapy; 2003 May; 49(1-2):17-23. PubMed ID: 12714804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.